EDEM2 and central nervous system cancer: High-grade gliomas had stronger EDEM2 expression based on immunohistochemistry, and the expression of cluster of differentiation 68 (CD68), cluster of differentiation 4 (CD4), and cluster of differentiation 8 (CD8) was higher in the samples (Figure 9).